Phibro Animal Company Insiders

PAHC Stock  USD 52.26  0.99  1.93%   
Phibro Animal's insiders are aggressively selling. The analysis of insiders' sentiment of trading Phibro Animal Health stock suggests that all insiders are panicking at this time. Phibro Animal employs about 2.5 K people. The company is managed by 19 executives with a total tenure of roughly 87 years, averaging almost 4.0 years of service per executive, having 130.26 employees per reported executive.
Jack Bendheim  Chairman
Chairman of the Board and Presidentident, CEO
Thomas Dagger  President
Senior Vice President General Counsel, Corporate Secretary

Insider Sentiment 0

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2026-02-11Jack BendheimDisposed 14184 @ 51.62View
2026-02-10Jack BendheimDisposed 58014 @ 51.81View
2026-02-05Jack BendheimDisposed 110842 @ 48.38View
2026-02-04Jack BendheimDisposed 3520 @ 41.15View
2026-02-03Jack BendheimDisposed 9660 @ 41.47View
2026-01-30Jack BendheimDisposed 6693 @ 40.09View
2026-01-29Jack BendheimDisposed 6772 @ 40.12View
2026-01-23Jack BendheimDisposed 1235 @ 40.55View
2026-01-22Jack BendheimDisposed 13158 @ 41.98View
2026-01-21Jack BendheimDisposed 14687 @ 41.68View
2026-01-15Jack BendheimDisposed 2932 @ 40.02View
2026-01-14Jack BendheimDisposed 3651 @ 40.53View
2026-01-13Jack BendheimDisposed 7551 @ 40.32View
2026-01-09Jack BendheimDisposed 213 @ 40.16View
2026-01-07Jack BendheimDisposed 328 @ 40.09View
2025-12-11Jack BendheimDisposed 5752 @ 40.93View
2025-12-09Jack BendheimDisposed 1288 @ 40.19View
2025-12-08Jack BendheimDisposed 3520 @ 40.06View
2025-12-03Jack BendheimDisposed 3520 @ 40.77View
2025-11-26Jack BendheimDisposed 5280 @ 44.02View
Monitoring Phibro Animal's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Phibro Animal's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Phibro Animal's future performance. Based on our forecasts, it is anticipated that Phibro will maintain a workforce of about 2480 employees by March 2026.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Phibro Animal Management Team Effectiveness

The company has return on total asset (ROA) of 0.0834 % which means that it generated a profit of $0.0834 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.318 %, meaning that it created $0.318 on every $100 dollars invested by stockholders. Phibro Animal's management efficiency ratios could be used to measure how well Phibro Animal manages its routine affairs as well as how well it operates its assets and liabilities. At present, Phibro Animal's Return On Equity is projected to slightly decrease based on the last few years of reporting. At present, Phibro Animal's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 73.8 M, whereas Non Currrent Assets Other are forecasted to decline to about 15.5 M.
The current year's Net Income Applicable To Common Shares is expected to grow to about 42.5 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 35.2 M. Phibro Animal owns a total of 20.62 Million outstanding shares. The majority of Phibro Animal Health outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Phibro Animal Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Phibro Animal. Please pay attention to any change in the institutional holdings of Phibro Animal Health as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2002-09-30
Previous Quarter
40.9 M
Current Value
41 M
Avarage Shares Outstanding
43.7 M
Quarterly Volatility
9.2 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Some institutional investors establish a significant position in stocks such as Phibro Animal in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Phibro Animal, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Phibro Animal Workforce Comparison

Phibro Animal Health is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 348,469. Phibro Animal maintains roughly 2,475 in number of employees contributing less than 1% to equities under Health Care industry.

Phibro Animal Profit Margins

The company has Profit Margin (PM) of 0.06 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.220.28
Significantly Down
Pretty Stable
Operating Profit Margin0.06140.0767
Significantly Down
Pretty Stable
Pretax Profit Margin0.02760.0472
Way Down
Very volatile

Phibro Animal Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Phibro Animal insiders, such as employees or executives, is commonly permitted as long as it does not rely on Phibro Animal's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Phibro Animal insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2026-03-01
0.1613
5
31
 295,000 
 560,968 
2025-12-01
0.122
5
41
 175,000 
 351,474 
2025-09-01
1.5
9
6
 71,493 
 78,806 
2025-03-01
2.0
2
1
 35,000 
 30,000 
2021-03-01
0.5
1
2
 50,000 
 270,000 
2019-03-01
0.25
8
32
 41,340 
 116,010 
2018-12-01
0.3333
1
3
 10,000 
 20,000 
2018-09-01
0.2969
19
64
 435,440 
 739,920 
2018-06-01
0.2045
9
44
 551,060 
 566,120 
2018-03-01
0.3158
18
57
 399,227 
 732,229 
2017-12-01
1.0
2
2
 24,000 
 24,000 
2017-09-01
0.5345
31
58
 284,657 
 584,086 
2017-06-01
0.3049
25
82
 681,937 
 1,517,887 
2017-03-01
0.5676
21
37
 195,104 
 387,687 
2016-12-01
0.5
5
10
 9,338 
 18,676 
2016-06-01
1.0
2
2
 9,406 
 8,812 
2016-03-01
0.3704
20
54
 299,517 
 586,184 
2015-12-01
0.2931
34
116
 350,077 
 740,154 
2015-09-01
0.2623
32
122
 512,838 
 1,057,856 
2015-06-01
0.2742
17
62
 404,000 
 684,000 
2015-03-01
0.375
3
8
 12,000 
 143,644 
2014-12-01
0.0435
1
23
 4,000 
 946,361 
2014-09-01
0.5
2
4
 773,500 
 1,219,650 
2014-06-01
1.35
27
20
 106,800,505 
 196,390,934 

Phibro Animal Notable Stakeholders

A Phibro Animal stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Phibro Animal often face trade-offs trying to please all of them. Phibro Animal's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Phibro Animal's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jack BendheimChairman of the Board and Presidentident, CEOProfile
Ramon FuenmayorPresident RegionProfile
Thomas DaggerSenior Vice President General Counsel, Corporate SecretaryProfile
Jonathan BendheimDirector and President MACIE Region and General Manager of Israel OperationsProfile
Rob AukermanPresident RegionProfile
Todd ArmstrongPresident RegionProfile
Daniel BendheimExecutive Vice President Director, Corporate StrategyProfile
Michael GiambalvoPresident GroupProfile
Lisa EscuderoSenior Vice President-Human ResourcesProfile
Samson LiPresident RegionProfile
Daniel JDExecutive DirectorProfile
Mona DesaiVP ControllerProfile
Anthony CPAVP TreasurerProfile
Judith WeinsteinGeneral VPProfile
Larry MillerChief OfficerProfile
Damian FinioChief OfficerProfile
Jean FilippiPres RegionProfile
Richard JohnsonInterim OfficerProfile
Glenn DavidChief OfficerProfile
String symbol = request.getParameter("s");

About Phibro Animal Management Performance

The success or failure of an entity such as Phibro Animal Health often depends on how effective the management is. Phibro Animal management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Phibro management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Phibro management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.03  0.02 
Return On Capital Employed 0.12  0.15 
Return On Assets 0.03  0.02 
Return On Equity 0.15  0.16 
Please note, the presentation of Phibro Animal's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Phibro Animal's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Phibro Animal's management manipulating its earnings.

Phibro Animal Workforce Analysis

Traditionally, organizations such as Phibro Animal use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Phibro Animal within its industry.

Phibro Animal Manpower Efficiency

Return on Phibro Animal Manpower

Revenue Per Employee523.7K
Revenue Per Executive68.2M
Net Income Per Employee19.5K
Net Income Per Executive2.5M
Working Capital Per Employee208.9K
Working Capital Per Executive27.2M

Complementary Tools for Phibro Stock analysis

When running Phibro Animal's price analysis, check to measure Phibro Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phibro Animal is operating at the current time. Most of Phibro Animal's value examination focuses on studying past and present price action to predict the probability of Phibro Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phibro Animal's price. Additionally, you may evaluate how the addition of Phibro Animal to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon